Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

Contact
Request a demo
Request data updates
Add a company

Research

Companies
Investors
People

aVenture

Sitemap
Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage

Loading

Loading

Magnus Persson

AddedMar 31, 2024

UpdatedMay 1, 2026

Magnus Persson

Magnus Persson

Board Member, SLS Invest

Magnus Persson's Career

SLS Invest

Gothenburg, Västra Götaland County, SE

Board Member· Board

EIR Ventures

Stockholm, Stockholm County, SE

Co-Founder

Avalo Therapeutics

Avalo Therapeutics

Rockville, MD, US

Board Member· Board

Ascendx Spine

Winter Park, FL, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview

aVenture product preview

aVenture product preview

Magnus Persson's Career

SLS Invest

Investment FirmInvestment Firm62007Gothenburg, Västra Götaland County, SE

Board Member· Board

Leadership at SLS Invest

Mats LindahlBoard Member

Hakan BohlinBoard Member

Similar to SLS Invest

IndustrifondenStockholm, Stockholm County, SEest. 1979IndustrifondenStockholm, Stockholm County, SE · est. 1979

Industrifonden, a Swedish venture capital firm, invests in business, consumer tech, and life sciences.

Investment Firm49

Investor Growth CapitalStockholm, Stockholm County, SEest. 1968Investor Growth CapitalStockholm, Stockholm County, SE · est. 1968

Investor Growth Capital AB: A global venture capital firm investing in diverse life sciences sectors.

Investment Firm30

Innovations KapitalGothenburg, Västra Götaland County, SEest. 1994Innovations KapitalGothenburg, Västra Götaland County, SE · est. 1994

InnovationsKapital: A leading Nordic venture capital firm investing in ICT and Healthcare sectors.

Investment Firm30

Global Life Science VenturesMunich, Bavaria, DEest. 2000Global Life Science VenturesMunich, Bavaria, DE · est. 2000

Global Life Science Ventures: A German venture capital fund specializing in early and late-stage investments.

Investment Firm9

EIR Ventures

Investment FirmInvestment Firm152020Stockholm, Stockholm County, SE

Co-Founder

Leadership at EIR Ventures

Andreas SegerrosCo-Founder

Stephan ChristgauCo-Founder

Similar to EIR Ventures

TrueSight VenturesLondon, Greater London, GBest. 2018TrueSight VenturesLondon, Greater London, GB · est. 2018

TrueSight Ventures: A venture capital firm investing in pre-seed and seed-stage startups, focusing on tech solutions.

Investment Firm5

Eastoir VenturesLondon, Greater London, GBest. 2016Eastoir VenturesLondon, Greater London, GB · est. 2016

Eastoir Ventures: Transforming innovative ideas into thriving startups through strategic investments.

Investment Firm3

Purple VenturesBrno, South Moravian Region, CZest. 2019Purple VenturesBrno, South Moravian Region, CZ · est. 2019

European VC fund providing seed investments to promising early-stage fintech startups.

Investment Firm8

Venista VenturesCologne, North Rhine-Westphalia, DEest. 2004Venista VenturesCologne, North Rhine-Westphalia, DE · est. 2004

Venista Ventures: A tech-focused pre-seed investor supporting startups in Western Europe & the Nordics.

Investment Firm8

Avalo Therapeutics

Avalo Therapeutics

Public$46.5M422011Rockville, MD, US

Board Member· Board

Leadership at Avalo Therapeutics

Mitchell ChanBoard Member

Michael ColaBoard Member

Solomon H SnyderBoard Member

Gilla KaplanBoard Member

Isaac BlechCo-Founder

Garry NeilBoard Member

Similar to Avalo Therapeutics

Avalor TherapeuticsKenmore, WA, USMedical TreatmentsAvalor TherapeuticsKenmore, WA, US

Kenmore-based medical organization, Avalor Therapeutics, pioneers precision medicine.

Pre-Seed · $335k6

Avalyn PharmaSeattle, WA, USPharmaceuticalsest. 2011Avalyn PharmaSeattle, WA, US · est. 2011

Avalyn Pharma Inc.: Developing innovative therapies for Idiopathic Pulmonary Fibrosis.

Series C · $272.5M27

AvotresCedar Knolls, NJ, USCancer Therapy, Therapeuticsest. 2016AvotresCedar Knolls, NJ, US · est. 2016

Avotres: A biotech firm innovating therapies for immune diseases and potential cancer treatments.

Series A · $4M7

Ashvattha TherapeuticsRedwood City, CA, USBiopharmaceuticals, Therapeuticsest. 2015Ashvattha TherapeuticsRedwood City, CA, US · est. 2015

Ashvattha Therapeutics: Innovating biopharmaceuticals for human and veterinary use since 2016.

Series B · $98M42

Ascendx Spine

Pre-Seed$6M62004Winter Park, FL, US

Board Member· Board

Leadership at Ascendx Spine

Julian MackenzieFounder

Romano FerrariBoard Member

Similar to Ascendx Spine

FlexuspinePittsburgh, PA, USMedical Devicesest. 2003FlexuspinePittsburgh, PA, US · est. 2003

Flexuspine Inc.: Innovating spinal treatment with advanced medical device manufacturing.

Pre-Seed · $3.2M7

SpineOvationsCarlsbad, CA, USMedical Devicesest. 2004SpineOvationsCarlsbad, CA, US · est. 2004

SpineOvations: Innovating spinal disorder diagnosis and treatment through advanced medical technology.

SpineFormCincinnati, OH, USMedical Devicesest. 2004SpineFormCincinnati, OH, US · est. 2004

SpineForm LLC: A US-based medical device company specializing in scoliosis treatment solutions.

Pre-Seed · $2.3M5

Spinal USAParsippany-Troy Hills, NJ, USMedical Devicesest. 2005Spinal USAParsippany-Troy Hills, NJ, US · est. 2005

Precision Spine: A US-based global provider of quality spinal products for healthcare professionals.

Angel · $258.4k75

Magnus Persson's Similar Executives & Operators

Lau Eng BoonBoard Member · Bukalapak

Jay Geoffrey WacherBoard Member · Bukalapak

Soemantri BrodjonegoroBoard Member · Bukalapak

Achmad ZakyCo-Founder · Bukalapak

Nugroho HerucahyonoCo-Founder · Bukalapak

Chi-hyung SongBoard Member · Dunamu

Haeil YiCo-Founder · Dunamu

Hyoung-nyon KimCo-Founder · Dunamu

People Similar to Magnus Persson

Jeff HansonCo-Founder · Core10

Gardiner F H SmithBoard Member · ThermalTherapeutic Systems

Ronald GoldBoard Member · NJ Bio

Robert AlpertBoard Member · P10

Bjarni ThorvardarsonCo-Founder · Hibernia Networks

Jeff HansonCEO · Core10